C-IV

AcronymDefinition
C-IVSchedule IV Controlled Substance (USA)
References in periodicals archive ?
Results: We compared serum levels of HA, LN, C-IV and PIII NP between FY*A/FY*A and FY*A/FY*B patients and the differences were not significant (P=0.
The company added that Eszopiclone Tablets (C-IV) 1 mg, 2 mg and 3 mg is the therapeutic equivalent generic version of LUNESTA (eszopiclone) tablets C-IV in the US market.
The county has trained librarians, food bank volunteers, local pharmacy staff and others to assist people in using C-IV and kiosk applications.
Revised labeling including a boxed warning for Redux (dexfenfluramine hydrochloride capsules) C-IV, which is marketed by Wyeth-Ayerst, has also been submitted to the FDA because it is a related chemical compound to fenfluramine.
Pharmaceutical company Transcept Pharmaceuticals Inc (Nasdaq:TSPT) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for Intermezzo C-IV for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.
With the implementation in the four consortium counties now completed, a group of 35 other counties currently using an older welfare system known as ISAWS and the State are investigating how to transition to the C-IV system.
The holiday season, a time when many Americans dread expected weight gains, can take on a new positive meaning this year for people with 30 or more pounds to lose - they can take the first step toward controlling their weight by applying for enrollment in Knoll Pharmaceutical Company's Mission Control(SM) MERIDIA(R)program, an unprecedented major national weight management program that will provide an opportunity to receive for free up to 12 months of the prescription weight-loss medication, MERIDIA(R)(sibutramine hydrochloride monohydrate) C-IV Capsules, with their doctors' approval.
Knoll Pharmaceutical Company today launched the Mission Control(SM) MERIDIA(R)program, an unprecedented major national weight management program that will provide people who have at least 30 pounds to lose with an opportunity to receive for free up to 12 months of the prescription weight-loss medication, MERIDIA(R)(sibutramine hydrochloride monohydrate) C-IV Capsules, with their doctors' approval.
Knoll Pharmaceutical Company announced today that it has begun the distribution of MERIDIA(R) (sibutramine hydrochloride monohydrate) Capsules C-IV to wholesalers, retailers, and pharmacies nationwide.
NASDAQ: IPIC) today announced the finalization of a three-year co-promotion agreement with Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE:AHP), in connection with today's launch of Redux (dexfenfluramine hydrochloride capsules) C-IV for marketing as prescription therapy for the management of obesity.
Food and Drug Administration (FDA) has cleared Redux (dexfenfluramine hydrochloride capsules) C-IV for marketing as prescription therapy for the management of obesity, including weight loss and maintenance of weight loss in patients on a reduced calorie diet.